Affidea Group appoints new CEO

The Board of the Affidea Group BV are pleased to announce the appointment of Mr. Giuseppe Recchi as the new Chief Executive Officer of the Group, effective immediately.

Giuseppe Recchi joins Affidea from Telecom Italia, where, since September 2017, he has been Deputy Chairman; having previously been Executive Chairman since April 2014. Prior to that, he was Chairman of the Board of Eni SpA from 2011 to 2014, before which he was at General Electric (GE), which he joined in 1999. There, he served as CEO of GE Capital Structure Finance Italia and as Managing Director for M&A in EMEA, before being appointed as President and CEO of GE South Europe. On 1 June 2017, he was awarded the title of ‘Cavaliere del Lavoro’ (Order of Merit for Labour) by decree of the President of the Italian Republic.

Richard Smith, Affidea’s Chairman, said; “Giuseppe is a world-class executive, and the Board and I are delighted he is joining us to lead the Affidea team. In Giuseppe, we have found exactly the right person to drive Affidea forward to realise its ambitions, and the Board and I are excited to begin this new phase of the group’s development with his experience and vision at the helm.”

Giuseppe Recchi said; “I am delighted to be joining Affidea and am looking forward to working with its hugely talented and dedicated #AffideaFamily. The vision of the Board and company shareholders is of a scale and purpose that matches my own, and I am eager to get started. I join a business that is in a strong position in all of its current areas of operation and I will be focusing my efforts on ensuring Affidea continues to deliver excellence to its customers in its existing and new markets, as well as helping it innovate and grow its role as a provider of superb healthcare.”

About the Affidea Group

Affidea is the leading Pan-European provider of diagnostic imaging and cancer treatment services, operating in 16 countries across Europe, with a focus on delivering timely, thorough diagnoses and high quality treatments by working only with state-of-the-art technology and experienced medical professionals. The Affidea Group employs almost 5,000 medical professionals and operates over 1,100 diagnosis and cancer care modalities with over 10 million diagnostic examinations every year. Affidea is owned by the trusts and funds associated with the Bertarelli family, which are managed by Waypoint Capital.

The foundation upon which Affidea has been built is trust. Both doctors and patients know that we strive to provide the best standard of care, delivered by the best professionals with the most modern technologies. Patients trust and rely on doctors. Doctors trust and rely on us.
What’s Affidea’s secret to transforming the standards of healthcare service provision? Our people. Healthcare professionals that know what they are doing and care about what they do. They make us who we are today. And who we want to be tomorrow.
We implement the highest standards and procedures to ensure safety. Affidea is committed to becoming the first European diagnostic provider to shape a new paradigm in patient safety by introducing a company wide Dose Excellence Programme ensuring the right balance between dose and image quality.
Affidea has an extensive network of international affiliations with the world’s top medical institutions to ensure that our doctors always have immediate access to the latest medical knowledge, clinical guidelines and medical procedures in all Affidea medical centres in order to ensure the highest quality diagnostics and cancer treatment.
We know that hospitality is important.  We care about how you feel and want to make each visit  to an Affidea centre as comfortable as we can.  An exceptional patient experience is ensured by delivering a personalised service in modern and comfortable service settings where you feel safe and confident that you are receiving the highest quality medical care.
Technology has done more for health today than it has ever done and will do even more in the future. Affidea is committed to operating a best in class medical equipment base and maintain it’s long standing relations with major equipment producers to ensure our patients will always have access to the latest, most innovative and effective technology.
We develop and exchange best practice. Patients deserve to know what we do, how we do it and why we do it. The continuous improvement of all Affidea care delivery processes is achieved by capitalising on the company’s extensive experience in 14 European countries and an organised effort to share best practice to improve patient safety and patient experience.